Dr. Bassel Abou-Khalil, MD

Dr. Abou-Khalil practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Abou-Khalil's NPI, 1568546679, was assigned on October 25, 2006. Dr. Abou-Khalil holds Tennessee license 18635.

Dr. Abou-Khalil's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Abou-Khalil's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Abou-Khalil to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abou-Khalil practices, 2 sites in all. Vendor and product names are available with a free account.

Clinical neurophysiology is Dr. Abou-Khalil's primary specialty in the NPI Registry, under taxonomy code 2084N0600X. Dr. Abou-Khalil is licensed in Tennessee.

CMS data shows 670 Medicare services from Dr. Abou-Khalil across 9 procedure codes in 2024, for 255 Medicare patients. Medicare paid $38,457 for them.

CMS counts 255 Medicare patients who saw Dr. Abou-Khalil in 2024. The largest group is under 65, with 101 patients. 68% of them have high blood pressure, and 62% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abou-Khalil's median patient age at 57, with 58% women.

In 2024, Dr. Abou-Khalil wrote 4,595 Medicare Part D claims for 294 patients. 70% of them were for generic drugs. CMS names the drug for 4,487 of them, across 52 drugs with 11 or more claims each, at $3,465,996 in total drug cost. In 2023, CMS named 4,531 claims across 53 drugs.

Dr. Abou-Khalil accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abou-Khalil as offering telehealth.

Dmand AI links 72 papers to Dr. Abou-Khalil, published from 2005 to 2025. 2017 was the busiest year, with 6. The most frequent topics are Anticonvulsants, Electroencephalography and Seizures. Dr. Abou-Khalil has published most often in Epilepsy Behav. Dr. Abou-Khalil's most frequent co-authors are Hasan Huseyin Sonmezturk, MD, Victor Biton, MD and Jonah Fox, MD.

Dmand AI links Dr. Abou-Khalil to 2 clinical trials. Conditions studied include Epilepsy, Epilepsies, Partial and Brain Diseases.

CMS Open Payments shows 8 general payments to Dr. Abou-Khalil from 5 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 62% of the total. GlaxoSmithKline, LLC. paid the most, $433.